These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38277155)

  • 41. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC; Quilliam BJ
    Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study.
    Picard S; Hanaire H; Baillot-Rudoni S; Gilbert-Bonnemaison E; Not D; Reznik Y; Guerci B
    Diabetes Technol Ther; 2016 Mar; 18(3):127-35. PubMed ID: 26950530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits of short-term professional continuous glucose monitoring in clinical practice.
    Leinung M; Nardacci E; Patel N; Bettadahalli S; Paika K; Thompson S
    Diabetes Technol Ther; 2013 Sep; 15(9):744-7. PubMed ID: 23786229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
    Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
    Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
    Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
    J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Pilot Trial of Continuous Glucose Monitoring Upon Emergency Department Discharge Among People With Diabetes Mellitus.
    O'Connor MJ; Ding X; Hernandez C; Hubacz L; Church RJ; O'Connor L
    Endocr Pract; 2024 Feb; 30(2):122-127. PubMed ID: 37952581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. INPATIENT HYPOGLYCEMIC EVENTS IN A COMPARATIVE EFFECTIVENESS TRIAL FOR GLYCEMIC CONTROL IN A HIGH-RISK POPULATION.
    Welsh N; Derby T; Gupta S; Fulkerson C; Oakes DJ; Schmidt K; Parikh ND; Norvell JP; Levitsky J; Rademaker A; Molitch ME; Wallia A
    Endocr Pract; 2016 Sep; 22(9):1040-7. PubMed ID: 27124695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
    ; Beck RW; Hirsch IB; Laffel L; Tamborlane WV; Bode BW; Buckingham B; Chase P; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Huang ES; Kollman C; Kowalski AJ; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer SA; Wilson DM; Wolpert H; Wysocki T; Xing D
    Diabetes Care; 2009 Aug; 32(8):1378-83. PubMed ID: 19429875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
    Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    Diabetes Technol Ther; 2022 May; 24(5):332-337. PubMed ID: 35104159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.
    Kuroda A; Taniguchi S; Akehi Y; Mori H; Tamaki M; Suzuki R; Otsuka Y; Matsuhisa M
    J Diabetes Sci Technol; 2017 Nov; 11(6):1096-1100. PubMed ID: 28992720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
    Levitt DL; Spanakis EK; Ryan KA; Silver KD
    Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of recurrent hypoglycemia following a severe hypoglycemic event among hospitalized patients.
    D'Netto M; Murphy CV; Mitchell A; Dungan K
    Hosp Pract (1995); 2016; 44(1):1-8. PubMed ID: 26652306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
    Hakeam HA; Mulia HA; Azzam A; Amin T
    JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycemic improvement with a novel interim intervention technique using retrospective professional continuous glucose monitoring (GLITTER study): A study from Mumbai, India.
    Jain AB
    Diabetes Metab Syndr; 2021; 15(3):703-709. PubMed ID: 33813245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.